Treatment of mild subclinical hypothyroidism and its impact on lipid metabolism
BackgroundHypothyroidism, both overt and subclinical, is associated with dyslipidemia and increased cardiovascular risk which is not completely corrected by thyroid hormone replacement therapy. In patients with subclinical hypothyroidism, when TSH levels are <10 mIU/L, dyslipidemia is considered...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Frontiers Media S.A.
2026-06-01
|
| Cyfres: | Frontiers in Endocrinology |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.frontiersin.org/articles/10.3389/fendo.2026.1847857/full |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|